The comparative effects of oral famotidine and lansoprazole in prophylaxis of aspirin induced peptic ulcer in albino rat
DOI:
https://doi.org/10.18203/2320-6012.ijrms20211348Keywords:
NSAIDs, Helicobacter pylori, H2 Receptor blockers, Proton pump inhibitorsAbstract
Background: Peptic ulcer is defined as any break in the continuity of gastric or duodenal epithelial layer. There are mainly three factors which are responsible for peptic ulcer disease which are Helicobacter pylori infections, NSAIDs and stress. Famotidine is H2 receptor blocker and Lansoprazole is proton pump inhibitor which are used prophylactically in aspirin induced peptic ulcer.
Methods: The experimental work was carried out on albino rat. Experiment was carried out with two ulcer protecting agents e.g-famotidine, lansoprazole and one ulcer producing agent Aspirin. Each ulcer protecting drug was used separately but simultaneously with aspirin to see their ulcer protecting efficacy. There was three groups of animals each consisting of ten albino rats. Ist group was control group which was given aspirin only.2nd group was given aspirin+famotidine, 3rd group was given aspirin+lansoprazole.
Results: The prophylactically ulcer preventing activity was the most with lansoprazole and least with famotidine.
Conclusions: Finally, all the two drugs like famotidine, lansoprazole prevented the ulcerogenic effects of Aspirin effectively, although not completely.
Metrics
References
Waren JR, Marshall BJ. Unidentified curved bacillion gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-5.
Hawkey CJ, Prichard PJ; Somerville KW; Strategies for preventing aspirin induced gastric bleeding. Scand J Gastroenterol. 1986;21:170-3.
Guth PH, Paulsen E. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterol. 1979;76:88.
Prichard PJ, Mitchingam GM, Walt RP. Human gastric mucosal bleeding induced by low dose aspirin but not warfarin. BMJ. 1985;298:493-6.
Rotter JI. 1979 Duodenal ulcer disease associated with elevated serum pepsinogen. Engl J Med. 1986;300:63.
Friedman GD. Cigarette, alcohol, coffee and peptic ulcer. N Engl J Med. 1974;290:469.
Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987;28:527-32.
Wastell C, Lance P. Cimetidine The Westminister Hospital Symposium. Edinburg, Churchill Livingstone. 1987.
Rogenes PR, Berkowitz JM, Sharp JT, Warner CW. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Arch Intern Med. 1987;147:2137-9.
Lindberg P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Trends in Pharmacol Sci. 1987;8:399-402.
Hirschowitz BI, Mohnen J, Shaw S. Long-term treatment with lansoprazole for patients with Zollinger-Ellisonsyndrome. Aliment Pharmacol Ther. 1996;10(4):507-22.
Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. Drug Safety. 1999;20(6):527-43.
Downloads
Published
How to Cite
Issue
Section
